Description
In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs. Sherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.- Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more. - Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Table of Contents
Pathobiology of Metabolic-Associated Fatty Liver DiseaseMetabolic-Associated Fatty Liver Disease in Childhood and AdolescenceLean Metabolic-Associated Fatty Liver DiseaseLipid Disorders and Metabolic-Associated Fatty Liver DiseaseCardiovascular Implications of Metabolic Dysfunction-Associated Fatty Liver DiseaseMetabolic-Associated Fatty Liver Disease and Diabetes: A Double WhammyMetabolic-Associated Fatty Liver Disease and the Gut MicrobiotaMetabolic-Associated Fatty Liver Disease and SarcopeniaA Bidirectional Association Between Obstructive Sleep Apnea and Metabolic[1]Associated Fatty Liver DiseasePregnancy and Metabolic-Associated Fatty Liver DiseaseThe Interlink Between Metabolic-Associated Fatty Liver Disease and Polycystic Ovary SyndromeManagement of Metabolic-Associated Fatty Liver Disease
